Page 496 - O_Desenvolvimento_do_Autismo
P. 496

_____.; ARORA, R.; ANDERSON, G.; BERRY-KRAVIS, E.; YAN, S.;
                YEOH, H.; SKLENA, P.; CHARAK, D. e LEVENTHAL, B. L. “Platelet
                serotonin studies in hyperserotonemic relatives of children with autistic

                disorder”. Life Sciences 52(25), 1993, pp. 2.005-2.015.






                _____.; COURCHESNE, R.; LORD, C.; COX, N. J.; YAN, S.; LINCOLN,
                A.; HAAS, R.; COURCHESNE, E. e LEVENTHAL, B. L. “Evidence of
                linkage between the serotonin transporter and autistic disorder”. Molecular
                Psychiatry 2(3), 1997, pp. 247-250.






                _____.; KARNS, C.; DAVIS, H.; ZICCARDI, R.; CARPER, R. A.; TIGUE,
                Z. D.; CHISUM, H. J.; MOSES, P.; PIERCE, K.; LORD, C.; LINCOLN, A.
                J.; PIZZO, S.; SCHREIBMAN, L.; HAAS, R.; AKSHOOMOFF, N. e
                COURCHESNE, R. “Unusual brain growth patterns in early life in patients

                with autistic disorder, an MRI study”. Neurology 24, 57(2), 2001, pp. 245-
                254.






                _____.; PERRY, B.; DAWSON, G.; WAINWRIGHT, M. e LEVENTHAL, B.
                “Receptor inhibition by immunoglobulins: specific inhibition by autistic
                children, their relatives, and control subjects”. Journal of Autism and
                Developmental Disorders 23(1), 1993, pp. 67-78.







                _____. e PIERCE, K. “An inside look at neurobiology, etiology, and future
                research of autism”. Advocate, julho-agosto de 2000, pp. 18-22.






                _____.; ROWLETT, R.; JASELSKIS, C. e LEVENTHAL, B. L. “Fluoxetine
                treatment of children and adults with autistic disorder and mental
   491   492   493   494   495   496   497   498   499   500   501